Biocytogen Pharmaceuticals Enters Into License Agreement With Pheon Therapeutics
Exclusive License Agreement for an Oncological Target Antibody to Develop Best-In-Class ADC BEIJING & LONDON–(BUSINESS WIRE)– Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315), a...